Skip to main content

Actuate Therapeutics, Inc.

ACTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001652935

No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Actuate Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
+10 vs. Q2 2024
Shares held
382.2K
+382.2K vs. Q2 2024
Total value
$2.85M
+$2.85M vs. Q2 2024
New holders
10
0 more added
Sold out
0
0 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 10 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 10 institutionsQ4 2024: 19 institutionsQ1 2025: 25 institutionsQ2 2025: 38 institutionsQ3 2025: 43 institutionsQ4 2025: 45 institutionsQ1 2026: 61 institutionsQ2 2026: 62 institutions
Value heldQ3 2024: $2.85M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $2.85MQ4 2024: $80.5MQ1 2025: $70.4MQ2 2025: $68.5MQ3 2025: $80.5MQ4 2025: $80.2MQ1 2026: $38.0MQ2 2026: $20.6M
Institutions holding ACTU and their total value by quarter
QuarterHoldersValue
Q2 202662$20.6M
Q1 202661$38.0M
Q4 202545$80.2M
Q3 202543$80.5M
Q2 202538$68.5M
Q1 202525$70.4M
Q4 202419$80.5M
Q3 202410$2.85M
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Actuate Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding ACTU in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
AWM Investment Company, Inc.139,511$1.04M0.13%+139,511New
Long Corridor Asset Management Ltd125,000$931.3K0.82%+125,000New
Royal Bank of Canada35,300$263.0K0.00%+35,300New
Geode Capital Management, LLC27,893$207.8K0.00%+27,893New
Northwestern University27,778$206.9K0.24%+27,778New
KG&L Capital Management,LLC12,000$89.4K0.03%+12,000New
Citigroup Inc10,973$81.7K0.00%+10,973New
Wells Fargo & Company3,392$25.3K0.00%+3,392New
Tower Research Capital LLC (TRC)297$2.21K0.00%+297New
Bank of America Corp23$1710.00%+23New